Schedule 13G ownership disclosure

KARUNA THERAPEUTICS INC

Security class unavailable · CUSIP: 48576A100

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
1,424,161
Percent of class
5.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000080255-21-001325
Form type
SC 13G
Filer
Karuna Therapeutics, Inc.
CIK
CIK 1771917
Filed
Feb 16, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub